CV SUMMARY: CAPT Wanda Denise Barfield, MD, MPH, FAAP

Barfield, Wanda D., PHS # 67128 Page 1 of 23 CV SUMMARY: CAPT Wanda Denise Barfield, MD, MPH, FAAP Career Progression/Mobility/Training/Experience Ju...
Author: Shona Doyle
42 downloads 0 Views 454KB Size
Barfield, Wanda D., PHS # 67128 Page 1 of 23

CV SUMMARY: CAPT Wanda Denise Barfield, MD, MPH, FAAP Career Progression/Mobility/Training/Experience Jun 10-Present Medical Officer IV (Supervisory), 0-6 USPHS, Director, Division of Reproductive Health (DRH) National Center for Health Promotion and Disease Prevention (NCCDPHP), Centers for Disease Control and Prevention (CDC), Atlanta, GA Jul 08-May 10 Medical Officer IV, 0-6, USPHS, Team Leader, Maternal and Child Health Epidemiology Program (MCHEP), Applied Sciences Branch (ASB), DRH, NCCDPHP, CDC Jul 06-Jun 09 Medical Officer IV, 0-6, USPHS, Senior Scientist, MCHEP, ASB, DRH, NCCDPHP, CDC Sep 03-Jun 06 Medical Officer IV, 0-5, USPHS, CDC Assignee, Massachusetts Dept of Public Health, Boston, MA Jul 02-Aug 03 Medical Officer III, 0-4, USPHS, Pregnancy Risk Assessment Monitoring System (PRAMS), ASB, DRH, NCCDPHP, CDC Jul 00-Jun 02 Medical Officer II, 0-4, USPHS, Epidemic Intelligence Service (EIS), Pregnancy and Infant Health Branch (PIHB), DRH, NCCDPHP, CDC Jul 00 Inter-service transfer from U.S. Army to U.S. Public Health Service Jul 98-Jul 00 Commissioned Officer, 0-4, U.S. Army, Director, Neonatal Intensive Care Unit, Department of Pediatrics, Madigan Army Medical Center (MAMC), Tacoma, WA Jul 96-Jun 98 Commissioned Officer, 0-4, U.S. Army, Assistant Chief, Newborn Medicine, Dept of Pediatrics,MAMC Jul 93-Jun 96 Inactive Reserve Officer, 0-3, U.S. Army, Fellow, Neonatal/ Perinatal Medicine, Joint Program in Neonatology, Harvard Medical School, Boston, MA Jul 90-Jun 93 Commissioned Officer, 0-2 and 0-3, U.S. Army, Intern and Resident, Department of Pediatrics, Walter Reed Army Medical Center, Washington, DC Education 1990 M.D. Harvard Medical School, Boston, MA 1990 M.P.H. Harvard School of Public Health, Boston, MA 1985 B.S. University of California, Irvine, CA Professional Certification/ Licensure/Membership 2014 Associate Professor, Pediatrics, Uniformed Services University of the Health Sciences 2012 American Pediatric Society (APS) 2011 Assistant Professor, Pediatrics, Emory School of Medicine 2007 CDC/PHS Liaison to American Academy of Pediatrics (AAP), Committee on Fetus and Newborn 2005 Society for Pediatric Research (SPR) 2000 Physician, State of Georgia, Lic. # 049268 (exp. 3/31/15) 1997 American Board of Pediatrics - Neonatal-Perinatal Medicine #232426 (exp. 2/1/2015) 1993 Physician, Commonwealth of Massachusetts, Lic. # 77056 (exp. 3/16/16) 1993 American Board of Pediatrics - General Pediatrics (exp. 12/2014) Selected Awards-USPHS and US Army (year) Outstanding Service Medal (11’) Commendation Medal (05’) Citation Medal (02’, 03’, 09’) Outstanding Unit Commendation (02’, 07’,10’14’) Unit Commendation (01’,06’, 11’, 12’, 14’) Crisis Response Service Award (02’, 06’, 08’) Special Assignment Award (08’, 10’) U.S. Army Commendation Medal(93’, 00’, 06’) U.S. Army Superior Unit Award (90’)

Selected Awards-Non-Uniformed Service (year) CDC Ebola Response (15’) HHS Secretary;s Innovation Award (14’) CDC/ATSDR Director’s Award for Public Health Impact (14’) Amer Med Student Assn, Women Leaders in Medicine (14’) Norman J. Siegel Outstanding Research Award, APS (12’) CDC Excellence in Emergency Response (10’) Nat’l Maternal Child Health Epidemiology Award (07’) HHS Secretary’s Award for Distinguished Service (06’) AAP Young Investigator Award (96’)

Response Readiness/Service -PHS Medical Category Promotion Board (upper board) -Deputy Team Leader and Chief Operations Officer, PHS-3 RDF (Atlanta/Raleigh; 2006-2009) -Deployments: NYC (2001) for 9/11 terrorist attacks; U.S. Army NICUs to backfill Iraq-deployed neonatologists (20042012); College Station & Marlin, TX for Hurricane Rita (2005); Atlanta GA for Hurricane Ernesto (2006); Baton Rouge, LA for Hurricanes Gustav and Ike (2008); CDC H1N1 Influenza, Maternal Health Team (2009-2010), CDC Ebola, Maternal Team (2014-2015), CDC Zika, Pregnancy and Birth Defects Team (2016-present)

3/11/2016

Barfield, Wanda D., PHS # 67128 Page 2 of 23

CURRICULUM VITAE Wanda Denise Barfield, MD, MPH, FAAP Captain, United States Public Health Service (USPHS) BUSINESS ADDRESS: Division of Reproductive Health National Center for Chronic Disesase Prevention and Health Promotion Centers for Disease Control and Prevention 4770 Buford Highway, Mailstop F-74, Atlanta, GA 30341 Phone: (770) 488-6231 Fax: (770) 488-6450 e-mail: wjb5@cdc .gov HOME ADDRESS: 3939 LaVista Road, #199 Tucker, GA 30084 Phone: (678) 481-3726 EDUCATION: 1985-90 1988-89 1981-85

M.D. M.P.H. B.S.

Harvard Medical School, cum laude Harvard School of Public Health, General Studies University of California, Irvine, Biological Sciences, cum laude

POSTGRADUATE TRAINING: 2000-02 Epidemic Intelligence Service (EIS), Centers for Disease Control and Prevention (CDC), Atlanta, GA 1993-96 Fellowship in Neonatal/ Perinatal Medicine, Joint Program in Neonatology, Harvard Medical School, Boston, MA 1991-93 Internship/Residency in Pediatrics, Walter Reed Army Medical Center, Wash, D.C. PROFESSIONAL LICENSURE/ CERTIFICATION: 2000 Physician, State of Georgia, Lic. # 049268 (exp. 3/31/15) 1993 Physician, Commonwealth of Massachusetts, Lic. # 77056 (exp. 3/16/16) 1997 American Board of Pediatrics - Neonatal-Perinatal Medicine (exp. 2/2021) 1993 American Board of Pediatrics - General Pediatrics (exp. 12/2016) ACADEMIC APPOINTMENTS: 2014-present Associate Professor of Pediatrics, Uniformed Services University of the Health Sciences, Bethesda, MD 2011-present Assistant Professor of Pediatrics, Emory University, Atlanta, GA

PROFESSIONAL INTERESTS AND GOALS: To improve reproductive, maternal, perinatal, and infant health domestically and globally through the effective use of surveillance and research; evidence-based clinical and programmatic interventions; and policy at the population level.

3/11/2016

Barfield, Wanda D., PHS # 67128 Page 3 of 23

PUBLIC HEALTH/CLINICAL EXPERIENCE: June 2010- present Director, Division of Reproductive Health NCCDPHP,CDC, Atlanta, GA Major Duties  Provide strategic vision and leadership in global and domestic efforts to promote optimal and equitable reproductive health and quality of life through research and program implementation.  Collaborate with local, tribal, regional, state, national, federal, and international governments and organizations in improving reproductive, maternal, and infant health; promote and increase national and global strategic partnerships in reproductive health in order to move science to practice  Effecitvely use CDC’s Safe Motherhood and Teen Pregnancy Prevention Initiative resources to impact CDC/HHS priority areas specifically, to prevent teen/unintended pregnancy, maternal mortality, preterm birth, and infant death. Main Accomplishments/Impacts  Leads a Division (SES/0-7 billet) of over 180 headquarters and field employees (medical officers, doctoral scientists, statisticians/economists, public health advisors, management officials, students/fellows, including 20 USPHS officers) with a domestic budget of over $43 million and international budget of $3.1 million.  Identified a strategic planning process within the first 30 days; communicated to entire division within 70 days. Refined Division’s priority areas in infant health, prepnancy health, and women’s reproductive health; developed new mission/vision/strategic focus areas within 1 year. Strengthened Division’s global health activities to address President’s Global Health Initiative and Millenium Development Goals (MDG) in maternal and infant mortality reduction. Created new branch for national and global maternal/ perinatal health field support. Improved USG effort to reduce global maternal mortality in districts in Zambia and Uganda.  Promoted and supported 1st proof-of-concept effort to reduce global maternal mortality—Saving Mothersresults Giving Life Initiative (CDC, USAID, DoD, Govt. of Norway, Merck for Mothers, ACOG, Columbia Univ., others). DRH leads maternal mortality measurement, monitoring, and evaluation in targeted districts in Zambia, Uganda, Malawi, and Tanzania. This US Government collaboration resulted in a 30% decline in maternal mortality in Zambia & a 35% decline in Uganda within 1 year leadership in global reproductive, maternal and infant health, DRH has been designated CDC’s lead global reproductive, maternal and infant health.  Reestablished DRH as a World Health Organization Collaborating Center.  Promoted 6 formal collaborations with CMS, OPA, OAH, NIH, HRSA, and USAID through Interagency Agreements totaling $13.5M to provide direct technical support to countries, states, tribes, and communities. Improved data and measures  Continued multi-agency HHS collaboration of President’s Teen Pregnancy Prevention Initiative; achieving success in CDC’s “Winnable Battle”. DRH led community-based, minority-focused, evaluations; increased use of effective contraception in grantee sites, increased awareness of US repeat teen pregnancy (1 in 5); engagement of clinical partners (125,000 members) promoted long-acting reversible contraception for teens; met CDC 2015 teen pregnancy goal in 2013.  Funded 12 state perinatal collaboratives and infant death case registries. Provided leadership and technical assistance with federal and national partners to 20 Southern/ MidWest states on Collaborative on Innovation and Improvement Network (CoIIN) for infant mortality reduction. Increased state focus on reducing infant mortality, disparities, late preterm births, regionalization.  Renewed collaboration with ACOG, MCHB/HRSA , SMFM and others to standardize state maternal mortality surveillance and review committees in the US with specific emphasis on implementation of preventive interventions.  Forged a first-ever federal collaboration (via interagency-agreement) with DRH and Centers for Medicaid/Medicare Services (CMMI/CMCS) to provide direct technical assistance (through a DRH/CDC

3/11/2016

Barfield, Wanda D., PHS # 67128 Page 4 of 23









 







assignee to CMS) for the $ 41.4 million CMMI “Strong Start for Mothers and Newborns” Initiative to reduce early preterm birth through innovative prenatal care models. Leads CDC’s successful inter-agency HHS collaboration on the President’s Teen Pregnancy Prevention Initiative (with ACF, ASPE, ASPR, OAH, OPA, and OWH: $100M/year, 5-years). Conducting unified evaluation strategy for evidenced-based teen pregnancy prevention programs, with DRH leading economic evaluation. Demonstrated positive progress on CDC’s “Winnable Battle” of teen pregnancy prevention. Visioning a clear 5-point public health approach (effective clinical interventions, community engagement, state policy, social media, and social determinants) resulting in declines in sexual activity, increased use of effective contraception, broad engagement of clinical providers in clinical guidelines (ACOG, AAP promoting long-acting reversible contraception in teens—125,000 medical members collectively) with 12% decline in teen births (2012). Negotiated and received $1.1M funding support from CDC Foundation and JW Kellogg Foundation to broaden and improve surveillance and evaluation capacity using DRH’s Pregnancy Risk Assessment Monitoring System in 3 high-risk communities in Louisiana, New Mexico, and Mississippi. Through proactive vision for emergency preparedness, DRH has a “ready” position for disasters/epidemics/bioterrorism among pregnant and postpartum women. Division’s efforts increased the percentage of pregnant/postpartum women vaccinated against H1N1, provided guidance for systems of Emergency Mass Critical Care for pregnant women and infants, provided evidence-based guidance for pregnant woman and infants on HHS-wide collaboration on anthrax, and increased awareness of need for reproductive health considerations in the Strategic National Stockpile (SNS). Funded 9 states in a focused population-based SUID case registry. Success of CDC/SUID case registry (increased case completeness from 44% to 94%) has changed national prevention efforts from “back to sleep” to “safe to sleep” due to the increased awareness of accidental suffocation and strangulation in bed and other causes of sleep related deaths. Provided programmatic assistance to 3 state-based Perinatal Quality Collaboratives (CA, NY, OH) to collect timely data for improving perinatal care. Collaborated with HRSA/MCHB, 13 US Southern states and national partners on prevention of infant mortality through reduction of 1) preterm birth 2) smoking in pregnancy 3) SIDS/SUID and promotion of 4) risk-appropriate care and 5) preconception care through family planning. Maintained scientific productivity with 8 peer-reviewed publications, 2 editorials in leading peer-review journals, 5 abstract submissions, reviewer for 4 scientific journals, senior editor for a special issue of the Maternal Child Health Journal and author of 2 chapters in AAP/ACOG Guidelines for Perinatal Care. Received PHS unit communication for promotion of state-based data linkage. Increased DRH’s scientific dissemination (200+ publications/year). Productive and well respected CDC representative to national organizations: CDC Liaison to 2 AAP Sections and 1 Committee; Ex-Officio member to HHS Secretary’s Advisory Committee on Infant Mortality. Selected for Membership to Pediatric Academic Society and American Pediatric Association. Provided care to over 350 critially ill newborns (2013) and supervised over 40 residents, fellows, and nurse practitioners as an attending neonatologist at Emory School of Medicine/Grady Hospital in Atlanta, GA

July 2008- May 2010 Team Leader, CDC Maternal Child Health (MCH) Epidemiology Program ASB, DRH, NCCDPHP,CDC, Atlanta, GA Major Duties  Improve MCH Epidemiology capacity nationally through the assignment of senior CDC MCH Epidemiologists to states and national organizations.  Collaborate with community, tribal, state, regional, federal, and international partners in advancing the field of MCH epidemiology

3/11/2016

Barfield, Wanda D., PHS # 67128 Page 5 of 23 

Develop strategic partnerships with key academic, private, and federal agencies to improve MCH outcomes

Main Accomplishments/Impacts  Immediately organized and produced a strategic plan to redefine roles of members and improve team collaboration that included advancing science internal operations partnership and evaluation. Increased scientific production of abstracts and manuscripts 5-fold over 3 years.  Supervised/mentored a branch-size team that grew from 6 to 23 staff upon starting the position to include a diverse cadre of 13 CDC/MCHEPI field assignees (CityMatch, District of Columbia, GA, HI, IA, LA, MA, MO, MS, OH, KY, US/Mexico Border); 10 Atlanta based staff and a survey advisor; 2 CDC-based fellows (EIS Officer and ORISE fellow), 3 specialty experts to support field activities (GIS, senior scientist, statistician), 2 contractors and a senior project officer. Recruited 1st EIS officer to branch in >10 years.  Reviewed and developed a $2.3 million program budget for FY09’ to include collaborations with HRSA/Maternal Child Health Bureau and national strategic partners. Finalized travel and program budgets for FY08’- FY10’ in order to conduct state site visits, new evaluate assignments and support MCH programs.  Lead 2-year ongoing yearlong collaboration on PRAMS research with analysis to inform Title V block grant renewals; over 160 web-based monthly participants involved; CDC lead in the linkage of PRAMS data to birth certificate, infant death certificate, and hospital discharge data in Massachusetts (PELL).  Chaired National Maternal Child Health Epidemiology Conference (08’-09’) and activities trained nearly 500+ participant scientists conferences including epidemiologists from Russia and Africa.  Provided direct technical assistance to a Northern Plains Tribe in assessing perinatal deaths. Resulted in ongoing collaboration, technical assistance, and recruitment of the first Native American CSTE fellow to the Tribal Epidemiology Center.  Partnered with the Council of State and Territorial Epidemiologists (CSTE) to fund and provide mentorship for 15 MCH fellows assigned to state health departments and over 2 years resulting in 93% retention of fellows to state health department jobs.  Deployed as Executive Officer of Rapid Deployment Force-3 Team to Baton Rouge Louisiana for Hurricane Gustav. Pre-staged, set-up, and staffed a 500-bed and 250-bed federal and state special needs shelter located in Louisiana State University’s Athletic Centers. Led 124 PHS officers and coordinated staffing of 100 clinical staff from Disaster Medical Assistance Teams (D-MATS) from Georgia, Massachusetts, Colorado, and California to provide care for over 600 medically complex evacuees.  Deployed a joint strategic plan with HRSA/MCHB to improve maternal child health epidemiology in the field  Reduced overexpendatures in travel costs due to late planning, and instituted efficient return of travel vouchers; saved program $17,000  Subject matter expert on 120 day detail for the care of newborns during 2009 H1N1 influenza epidemic; revised CDC guidance on infection control in obstetrical settings, engaged national experts in neonatalperinatal medicine on newborn care, isolation, and feeding of infants exposed to maternal H1N1 July 2006-June 2009 Senior Scientist/Medical Epidemiologist: CDC MCH Epidemiology Program ASB, DRH, NCCDPHP,CDC, Atlanta, GA Major Duties  Advance state-based maternal-child health (MCH) surveillance systems  Increase MCH analytic capacity in the field; review and critique and mentor scientific work with the team  Lead in the Commissioned Corps transformation. Main Accomplishments/Impacts

3/11/2016

Barfield, Wanda D., PHS # 67128 Page 6 of 23 









Acted as Division Associate Director for Science (ADS) Feb –Apr 2008; Reviewed over 50 abstracts, manuscripts, and review articles for direct clearance and cross clearance for DRH. Participated in a national partnership (academic, private, and government institutions) to address the life course perspective in reproductive health. Assisted in improving the scientific content of public communication messages on a variety of topics in reproductive health, provided technical review of information on stillbirths and sudden infant death syndrome. Built and led a CDC, state, and university collaborative to analyze longitudinally-linked maternal and infant health data. Pioneered work on the linkage of population-based vital events (birth, death), longitudinal health care utilization (hospitalizations, emergency department visits), and program services [Early Intervention (EI), Women Infants and Children (WIC), Medicaid] data for informing policy. Work will be used as a template of MCH longitudinal data systems for other states. Received the 2009 National Maternal Child Health Award for Effective State-Based Practice. Assisted in recruitment of 5 new maternal child health epidemiologists in Massachusetts, District of Columbia, Hawaii, Missouri, and Kentucky. Lead MCH epidemiologists in 5 peer-review publications, and 3 abstracts. Developed and organized a 105-member international network of state-based MCH epidemiologists involving 16 states and the U.S./Mexico border to analyze surveillance data using the Pregnancy Risk Assessment Monitoring System (PRAMS) in collaboration with the University of Illinois in Chicago (UIC). 15 abstracts accepted to a national research conference. Advanced to Deputy Team Leader of Tier-1 USPHS Rapid Deployment Force (RDF-3) based in Atlanta/Raleigh region after serving 9 months as Operations Section Chief and Chief Medical Officer. Exceeding readiness standards; completed FEMA IS modules, web-based IRCT, and advanced pediatric/neonatal life support. Recruited and facilitated training multi-category cadre of 92 officers. Led first Tier-1 team deployment since PHS transformation with pre-positioning of officers to Atlanta/Tallahassee in anticipation of Hurricane Ernesto (August 2006).

September 2003-June 2006 State Maternal-Child Health Epidemiologist: CDC MCH Epidemiology Program Bureau of Community and Family Health, Massachusetts Department of Public Health, Boston, MA Major Duties  Conduct analysis on racial and ethnic disparities in perinatal outcomes in state.  Establish new guidelines for existing perinatal referral systems in the state.  Improve and expand existing MCH surveillance systems for state and increase analytic capacity Main Accomplishments/Impacts  Analyzed state Early Intervention (EI) referral patterns for very low birth weight infants. Found that infants of uninsured or black mothers were less likely to be referred or referred early. Commissioner used these results to advocate for Medicaid waivers and the EI program improved minority outreach. Created and published first ever population-based costs of prematurity due to EI services by each week of preterm gestation, which informed the Institute of Medicine’s (IOM) national report on preterm births on the costs of EI services for preterm infants.  Organized 5 cities with largest racial disparities in perinatal outcomes to analyze local data and devise community action plans. Formulated statewide plan for reducing disparities to include revising state perinatal regulations to include cultural competency and ensure access to quality prenatal care and maternal and newborn services.  Increased MCH epidemiology capacity by recruiting and mentoring over 15 graduate students, fellows, and junior staff from programs at local schools of public health (Harvard, Boston University) and national fellowship programs (Council of State and Territorial Epidemiologists, Harvard Commonwealth Fellowship)

3/11/2016

Barfield, Wanda D., PHS # 67128 Page 7 of 23 



 





Led a state-wide multidisciplinary taskforce to examine current state regulations on hospital maternal and newborn care levels. Updated and improved required standards of care, incorporated systematic clinical data collection, and quality assurance monitoring, making the state a leader in perinatal regionalized systems. Led multidisciplinary collaboration with state neonatal intensive care units to monitor quality care and clinical outcomes of all newborns 28 Weeks Gestation, United States—1995-1998. Rev Esp Salud Publica 2002;76: 89. 11. Barfield WD, Flowers LM, Martin JA, Iyasu S, Tomashek KM. Unexamined Deaths: Perinatal Mortality in the United States, 1995-97. Paediatric and Perinatal Epidemiology 2001;15(4): A3. 12. Gries DM, Phyall G, Barfield WD. Evaluation of an Early Discharge Program of Mothers and Infants Following Childbirth in a Military Population. Pediatr Res 1997; 41(4); 151A: 894. 13. Barfield WD, Wampler NS, Wise PH. First Day Mortality: Impact on Racial Disparities in Neonatal Mortality. Pediatrics 1996; 98(3): 579. 14. Barfield WD, Wampler NS, Wise PH. Racial Equity in Neonatal Resuscitation: Evidence from First Day Mortality. Pediatr Res 1995:37(4); 249A: 1479. 15. Barfield WD, Wampler NS, Wise PH. Mandated Non-Resuscitation: Racial Discrimination against Premature Black Infants? Pediatr Res 1995:37(4); 249A: 1480. Selected Editorials/Book Chapters/Review Articles/Committee Statements/Reports 1. Eichenwald EC, and the Committee on Fetus and Newborn. Apnea of Prematurity. Pediatrics. 2016;137:e1-e6. 2. Benitz WE, and the Committee on Fetus and Newborn. Patent Ductus Arteriousus in Preterm Infants. Pediatrics. 2016;137;e1-e6. 3. Cummings J, and the Committee on Fetus and Newborn. Noninvasive Respiratory Support. Pediatrics. 2016;137:e1-e11. 4. American Academy of Pediatrics Committee on Fetus and Newborn, American College of Obstetricians and Gynecologists Committee on Obstetric Practice. The Apgar Score. Pediatrics. 2015;136:819-822. 5. Cummings, J and the Committee on Fetus and Newborn. Antenatal Counseling Regarding Resuscitation and Intensive Care Before 25 weeks of Gestation. Pediatrics. 2015; 136:586-594. 6. Bailey, J. and the Committee on Fetus and Newborn. Skin-to-Skin Care for Term and Preterm Infants in the Neonatal ICU. 2015; 136: 594-599. 7. Wang KS, Section on Surgery, Committee on Fetus and Newborn, and Childhood Liver Disease Research Network. Newborn Screening for Biliary Atresia. Pediatrics 2015;136:e1663-e1669. www.pediatrics.org/cgi/doi/10.1542/peds.2015-3570. 8. Gavin L, Moskosky S, Barfield WD. (eds.) Developing U.S. Recommendations for Providing Quality Family Planning Services. Am J Prev Med. 2015. Vol 49(2):Supplement 1. 9. Gavin LE, Moskosky SB, Barfield WD. Introduction to the Supplement. Developing U.S. Recommendations for Providing Quality Family Planning Services. Am J Prev Med. 2015.49:S1-S5. 10. Benitz WE and the Committee on Fetus and Newborn. Hospital Stay for Healthy Term Newborn Infants. Pediatrics 2015; 135: 948-953. 11. Warner L. Barfield W. CDC Releases National Public Health Action Plan for the Detection, Prevention, and Management of Intertility. Journ Womens Health. 2015 (in press) 12. Kissin DM, Jamieson DJ, Barfield WD. Monitoring Health Outcomes of Assisted Reproductive Technology. N Engl J Med. 2014 (in press) DOI:10.1056/NEJMc1404371. 13. American College of Obstetricians and Gynecologists and the Society for Maternal-Fetal Medicine, Menard MK, Saade G, Hollier L, Kilpatrick S, Joseph G, Barfield W, Callaghan W. Obstetric Care Consensus No. 2, American College of Obstetricians and Gynecologists. Obstet Gynecol. 2015;125:502-15. 14. Society for Maternal-Fetal Medicine, Menard MK, Saade G, Hollier L, Kilpatrick S, Joseph G, Barfield W, Callaghan W. Clinical Opinion: Levels of Maternal Care. Amer J Obstet Gyn. 2015 (in press). 15. Ruktanonchai D, Lowe M, Norton SA, Garrett T, Soghier L, MD, Weiss E, Hartfield J, Lapinski J, Abrams S, Barfield W. Zinc Deficiency-Associated Dermatitis in Infants During a Nationawide Shortage of Injectable Zinc – Washington, DC, and Houston, Texas, 2012–2013. MMWR 2014; 63: 35-37. 16. Papile LA, and the Committee on Fetus and Newborn. Clinical Report—Hypothermia and Neonatal Encephalopathy. Pediatrics. 2014;133:1146-1150.

3/11/2016

Barfield, Wanda D., PHS # 67128 Page 20 of 23

17. Carlo WA, Polin RA and the Committee on Fetus and Newborn. Policy statement – Respiratory Support in Preterm Infants at Birth. Pediatrics 2014; 133: 171 – 174. 18. Polin RA, Carlo WA and the Committee on Fetus and Newborn. Clinical Report – Surfactant Replacment Therapy for Preterm and Term Neonates with Respiratory Distress. Pediatrics 2014; 133: 156 -163. 19. Kumar P, and the Committee on Fetus and Newborn. Use of Inhaled Nitric Oxide in Preterm Infants. Pediatrics 2014; 133: 164-170. 20. Bowman BA, Pfeiffer CM, Barfield WD. Thiamin Deficiency, Beriberi, and Maternal and Child Health: Why Pharmacokinetics Matter. American Journal of Clinical Nutrition. 2013;98:635-6. 21. Watterberg KL, and the Committee on Fetus and Newborn. Planned Home Birth. Pediatrics. 2013;131:1016-1020. 22. Siegel BS, Davis BE, the Committee on Psychosocial Aspects of Child and Family Health, and Section on Uniformed Services. Health and Mental Health Needs of Children in US Military Families. Pediatrics. 2013;131:e2002-e2015, DOI:10.1542/peds.2013-0940. 23. Norton SA, Soghier L, Hatfield J, Lapinski J, Barfield WD. Zinc Deficiency Dermatitis in Cholestatic Extremely Premature Infants After a Nationwide Shortage of Injectible Zinc—Washingon, DC, December 2012. MMWR. 2013;62:136-137. 24. Behnke M, Smith V, the Committee on Substance Abuse and the Committee on Fetus and Newborn. Prenatal Substance Abuse: Short and Long-term Effects on the Exposed Fetus. Pediatrics 2013:131;e1009e1024, DOI:10.1542/peds.2012-3931. 25. Kimberlin DW, Baley J, Committee on Infectious Diseases and the Committee on Fetus and Newborn. Pediatrics. 2013;131:383-386. DOI: 10.1542/peds/2012-3217. 26. Kroelinger CD, Barfield WD, Callaghan WM. Expanding and Enhancing Federal, State, Tribal, and Academic Partnerships to Advance the Field of Maternal and Child Health. Matern Child Health J. 2012;16:S189-S192 (epub ahead of print November 30, 2012) DOI:10.1007/s10995-012-1193-6. 27. Rosenberg D, Barfield WD, Rankin K, Kroelinger CD. Increasing Scientific and Analytic Capacity in States: Extending Epidemiology Collaborations Beyond Traditional Workforce Development. Matern Child Health J. 2012;16:S193-S195 (epub ahead of print November 16, 2012) DOI:10.1007/s10995-012-1189-2. 28. Kroelinger CD, Barfield WD, Rosenberg D, Rankin KM, Callaghan WM (eds). Using Data, Sicence, and Partnerships: Promoting Innovation and Collaboration to Strengthen the Field of Maternal and Child Health Epidemiology [Special issue]. Maternal and Child Health Journal; 16 (suppl. 2):S189-S380. 29. Guidelines for Perinatal Care, American Academy of Pediatrics and American College of Obstetricians and Gynecologists –7th ed. Oak Grove Village, IL. 2012. 30. Barfield WD and the Committee on Fetus and Newborn. Policy Statement—Levels of Neonatal Care. Pediatrics 2012;130:587-597. 31. Wang KS, and the Committee on Fetus and Newborn and Secton on Surgery. Assessment and Management of Inguinal Hernia in Infants. Pediatrics 2012;130:768–773. 32. Zapata L, Kendrick J, Jamieson D, MacFarlane K, Shealy K, Barfield WD. Review Article: Prevention of Novel Influenza Infection in Newborns: Strategies Based on the 2009 H1N1 Pandemic. Disaster Med Public Health Preparedness 2012;6:97-103 (senior author). 33. Barfield WD. Improving Systems in Perinatal Care—Quality, not Quantity. JAMA.2012;307:1750-1751. 34. Hudak ML, Tan RC, The Committee on Drugs and the Committee on Fetus and Newborn. Clinical Report—Neonatal Drug Withdrawal. Pediatrics 2012 (epub ahead of print Jan 30, 2012) DOI: 10.1542/peds.2011-3212 35. Barfield WD, Warner L. Preventing Chronic Disease in Women of Reproductive Age: Opportunities for Health Promotion and Preventive Services. Prev Chronic Dis 2012;9:110281. DOI: http://dx.doi.org/10.5888/pcd9.110281. 36. Kissin D, Jamieson D, Barfield WD. Public Reporting of Clinical Outcomes of Assisted Reproductive Technology Programs – Letter to the Editor. JAMA 2011;306:2564. 37. Committee on Infectious Diseases and Committee on Fetus and Newborn. Policy Statement— Recommendations for the Prevention of Perinatal Group B Streptococcal (GBS) Disease. Pediatrics 2011;128:611-616.

3/11/2016

Barfield, Wanda D., PHS # 67128 Page 21 of 23

38. Bhutani VK, and the Committee on Fetus and Newborn. Clinical Report—Phototherapy to Prevent Severe Neonatal Hyperbilirubinemia in the Newborn Infant 35 or More Weeks of Gestation. Pediatrics 2011;128 e1046-e1052. 39. Barfield WD, and the Committee on Fetus and Newborn. Clinical Report—Standard Terminology for Fetal, Infant, and Perinatal Death. Pediatrics 2011 128;177-181 40. Barfield WD, Lee KG, Late Preterm Infants. UptoDate. February 16, 2011. Accessible at http://www.uptodate.com. 41. Adamkin, and the Committee on Fetus and Newborn. Clinical Report—Postnatal Glucose Homeostasis in Late-Preterm and Term Infants. Pediatrics 2011;127:575-579. (co-author) 42. Beiber E, Barfield WD, Dowling-Quarles S, Sparkman L, Blouin AS. Chapter 11: Systems Change Across the Continuum of Perinatal Care. In Berns SD, Kott A, eds. Toward Improving the Outcome of Pregnancy III: Enhancing Perinatal Health through Quality, Safety, and Performance Initiatives(TIOP3). White Plains, NY: March of Dimes Foundation, 2010. 43. Watterberg KL, and the Committee on Fetus and Newborn. Policy Statement—Postnatal Corticosteriods to Prevent or Treat Brochopulmonary Dysplasia. Pediatrics 2010; 126:800-808. (co-author) 44. Kumar P, Denson SE, Mancuso TJ, and the Committee on Fetus and Newborn, and Section on Anesthesiology and Pain Medicine. Clinical Report—Premedication for Nonemergency Endotracheal Intubation in the Neonate. Pediatrics 2010;125:608-615. (co-author) 45. Kumar P, and the Committee on Fetus and Newborn. Policy Statement—Hosptial Stay for Healthy Term Newborns. Pediatrics 2010;125;405-409. (co-author) 46. Wallman C, and Committee on Fetus and Newborn. Advanced Practice in Neonatal Nursing. Pediatrics 2009;123:1606-1607. (coauthor) 47. Rasmussen SA, Jamieson DJ, Macfarlane K, Cragan JD, Williams J, Henderson Z; Pandemic Influenza and Pregnancy Working Group. Pandemic influenza and pregnant women: summary of a meeting of experts. Am J Public Health 2009;99 Suppl 2:S248-54. 48. Barfield WD. Late Preterm Infants. UptoDate. June 15, 2009. Accessible at http://www.uptodate.com 49. Adams MM, Barfield WD. The Future of Very Preterm Infants—Learning from the Past. JAMA 2008; 299(12):1477-1478. 50. McCormick MC, Barfield W, Stolz JW. About Benefits and Costs: Pick on Someone Your Own Size. Sci Amer 1995;2(4):4. News Articles 1. Frey, Darcy. “Does Anyone Here Think This Baby Can Live?” The New York Times. July 9, 1995. Selected Presentations 1. CDC and Harvard T.H. Chan School of Public Health. 2016 Maternal and Child Health Program Evaluation Practicum. MCH at the CDC. January 4-8, 2016. 2. USPHS Scientific and Training Symposiumm Physician Category Day. Women and Infants in Times of Disaster: A Public Health Response to Global Epidemics. May 19, 2015. 3. HHS Secretary’s Avisory Committee on Infant Mortality (SAICM). Infant Mortality Prevention: Updates from CDC. April 24-25, 2013. 4. Association of Maternal and Child Health Programs Annual Conference, Washington, DC. Being Born at the RightPlace and the Right Time: Data and Definitions in Neonatal Levels of Care. February 2009. 5. Maternal Child Health Epidemiology Conference, Atlanta, GA. Using Longitudinally Linked Data to Improve Early Intervention Referral among High Risk Infants. November 2004. 6. Society for Pediatric and Perinatal Epidemiology Annual Meeting, Atlanta, GA. Racial Disparities in Late Fetal Deaths, United States—1995-1998. June 2003. 7. TEPHINET Conference, Madrid Spain, Characteristics of Stillbirths and Early Neonatal Deaths > 28 weeks Gestation, United States—1995-1998. June 2002. 8. American Public Health Association Annual Meeting, Atlanta, GA. Unexamined Deaths: Perinatal Mortality in the United States, 1995-1998. October 2001.

3/11/2016

Barfield, Wanda D., PHS # 67128 Page 22 of 23

Selected Invited Lectures 1. National Academy of Medicine, 2015 Annual Meeting. The Epidemiology of Infant Mortality in the International Context: Trends in Infant Mortality, Racial Disparities, International Comparisons. October 18, 2015. 2. Uniformed Services University of the Health Sceinces. Pediactric Grand Rounds “Infant Mortalty Prevention: Opportunities to Link Clinical Care and Population Health” Feburary 27, 2014 3. Centers for Disease Control and Prevention. Public Health Grand Rounds. Reducing Teen Pregnancy in the United States. March 19, 2013 Archived at http://www.cdc.gov/about/grandrounds/archives/2013/march2013.htm 4. Centers for Disease Control and Prevention. Public Health Grand Rounds. Public Health Approaches to Reducing U.S. Infant Mortality. October 16, 2012. Archived at: http://www.cdc.gov/about/grandrounds/archives/2012/October2012.htm 5. Pediatric Academic Societies, American Pediatric Society Plenary Session. Beginning with the End in Mind: Social Determinants and Disparities in Peinatal Health. April 29, 2012. 6. 7th World Congress on Developmental Origins of Health and Disease. Moderator: Origins of Childhood Obesity/Diabetes. September 21, 2011. 7. Office of Special Education and Rehabilitative Services. Social Determiants of Health: What do health disparities have to do with early childhood? August 1, 2011. 8. Institue of Medicine, Committee on Primary Care and Population Health. Primary Care and Population Health in Maternal and Child Health. August 1, 2011 9. Secretary’s Advisory Committee on Infant Mortality. Infant Mortality Prevention: A Community and Public Health Approach. August 2, 2011 10. U.S. Department of Health and Human Services. Teen Pregnancy Prevention: Evidence and Collaboration for Better Outcomes in Communities. May 10, 2011 11. Northern Manhattan Perinatal Partnership and Central Harlem Healthy Start Consortium Meeting, Harlem, NY. The Ties that Bind: Redefining MCH in the Age of Chronic Disease Management, Social Determinants of Health and Interconceptional Care. January 2011 12. United Nations Education, Scientific, and Cultural Organization, United Nations, NYC. Tobacco Exposure During Pregnancy. July 16, 2010 13. CDC Clinician Outreach Communication, H1N1 and Pregnant Women and Infants. November 2009. 14. Perinatal Symposium, Augusta, GA, Invited Speaker, Lessons Learned from Other State Perinatal Systems— What’s Working? June 2009 15. Hot Topics in Neonatology, Washington, DC, Guest Discussant, Newborn Levels of Care. December 2008 16. Maternal Child Health Epidemiology Conference, Atlanta GA, Plenary Moderator. Measuring and Eliminating Racism and Racial Disparities in Maternal and Child Health: The Need for New Paradigms. December 2008. 17. American Academy of Pediatrics National Conference and Exibition, Boston, MA. Guest Discussant. COFN Update: Levels of Newborn Care. October 2008. 18. Boston University School of Public Health, Invited Speaker, Eliminating Maternal and Child Health Disparities. June 2006. 19. Partners in Perinatal Health Annual Conference, Waltham, MA, Guest Speaker. Reducing Racial Disparities in Perinatal Outcomes: What Can Clinicians Do? May, 2006. 20. Partners in Perinatal Health Annual Conference, Waltham, MA, Guest Speaker. Revising the Perinatal Regulations: The Massachusetts Experience. May, 2006. 21. Madigan Army Medical Center Pediatric Lecture Series, Guest Lecturer. Reducing Racial Disparities through Clinical Linkage in Maternal Child Health-An Epidemiology Primer. July 2005. 22. Children’s Hospital Division of Newborn Medicine Lecture Series, Guest Speaker. Maternal Child Health Surveillance using Survey Data. March 2005 23. William A Hinton Lecture, Harvard School of Public Health. Guest Speaker/Discussant. Workforce Development: Partnering for Diversity in the Health Care Professions. February 2005.

3/11/2016

Suggest Documents